Sunshine Act

3.4.2013 Fair-Market Value

Transparency for FMV Rates: Finding a Balance Abroad

When France first released its 2011 draft of the Bertrand Act — which included a provision similar to the Sunshine Act here in the US – the legislation promised to be more stringent than US guidelines.  The draft required companies to post its payments on...
 

2.19.2013 Medical Affairs

Sunshine Act and the States

There has been much buzz about the Sunshine Act since the Centers for Medicare and Medicaid Services (CMS) released its final draft of guidelines.  Comparatively, there has been little mention as to how this legislation will affect individual states.  According...
 

2.7.2013 KOL Management

The Sunshine Act is Ready — Is Pharma?

At last.  Cue the Etta James music because the Centers for Medicare and Medicaid Services (CMS) released the final version of the Sunshine Act.  As of February 8, the Sunshine Act will be included in the Federal Register and will go into effect shortly thereafter....
 

12.21.2012 Strategic Planning

Happy Holidays!

As the year comes to a close, we would like to thank our readers, clients, and partners for their contributions toward helping Cutting Edge Information create benchmarking reports for the life sciences industry. With Sunshine Act responsibilities and continued...
 

4.21.2012 KOL Management

Drug Companies Embrace Transparency in Physician Compensation

The wave of pharmaceutical transparency laws has not yet crested, according to research from Cutting Edge Information, and drug companies are responding with steps to reveal their compensation to physicians. Cutting Edge Information's recent study "Pharmaceutical...
 

4.12.2012 Fair-Market Value

Physician Payment Disclosures and FMV Going Strong Despite Sunshine Act Delays

By Elio Evangelista, Director of Research The United States is still waiting for the Centers for Medicare and Medicaid Services (CMS) to issue its final ruling on how it will implement the disclosure rules outlined in the Physician Payments Sunshine...
 

1.30.2012 Fair-Market Value

Extended Sunshine Act deadline provides extra time to track and report physician payments

Six Tips to Help Build the Ideal Thought Leader Database As the industry awaits the release of the delayed Sunshine Act guidelines, pharmaceutical and medical device companies are benefiting from the extra time by reviewing current physician payment reporting...
 

12.6.2011 Fair-Market Value

Preliminary Work and Travel Costs Take Center Stage in FMV Calculations

New study provides process for calculating compliant fair-market value payments Although 100 percent of drug companies compensate key opinion leaders (KOLs) for their method of travel, only 60 percent do so for any preliminary work. And as mandatory public...
 

11.28.2011 Fair-Market Value

Drug and Device Companies Still Waiting For Sunshine Act Guidelines

By Elio Evangelista,Director of Research In about five weeks, pharmaceutical, biotechnology and medical device companies will have to start compiling and aggregating data on their physician expenditures to meet the requirements spelled out in the Physician...
 

11.8.2011 Fair-Market Value

Physician’s Conflict of Interest in Spotlight Again after BMJ Study Published

By Ryan McGuire,Senior Research Analyst A study published in the British Medical Journal has received a lot of attention lately. It highlighted the prevalence of financial conflicts of interest (COI) for researchers sitting on 14 specific guideline-setting...